Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4236 results

Sort By:

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

Study ID: NCT06906627
Start Date: 2025-08-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

(IRIS-CKD Screening Program): Home Kit

(IRIS-CKD Screening Program): Standard Lab Order

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

User Evaluation of Advanced Personalized Modular Pressure Relief Seating Cushion Systems

Study ID: NCT03494127
Start Date: 2026-08-23
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Use of GEL BALL FITTED MODULAR CUSHION

Use of SQUISHINS FITTED MODULAR CUSHION

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI

Study ID: NCT06848673
Start Date: 2026-11-01
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Office-Based Vergence/Accommodative Therapy with Movement (OBVAM)

Sponsor

Salus University

Source: clinicaltrials.gov

Share:
Add to list

Randomized Trial of SGLT2i in Heart Transplant Recipients

Study ID: NCT06625073
Start Date: 2025-08-01
End Date: 2030-02-28
Study Type

Interventional

Study Phase

Phase4

No. of Participants

200

Intervention / Treatment

Empagliflozin

Placebo

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation

Study ID: NCT07050173
Start Date: 2025-09-01
End Date: 2027-10-27
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Gamma-glutamylcysteine (GGC)

Sponsor

Pravat mandal

Source: clinicaltrials.gov

Share:
Add to list

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

Study ID: NCT07032727
Start Date: 2025-12-03
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

Olutasse

Cladribine (CLAD)

Venetoclax

Gillter

Rheops

Cytarabine

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Study ID: NCT07017673
Start Date: 2025-08
End Date: 2032-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Ivonescimab

Carboplatin

Docetaxel

Sponsor

Cedars-Sinai Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Oral Dexmedetomidine in Pediatric MRI

Study ID: NCT05619627
Start Date: 2025-08-01
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Dexmedetomidine

General Anesthesia (control group)

Sponsor

Children's Mercy Hospital Kansas City

Source: clinicaltrials.gov

Share:
Add to list

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

Study ID: NCT06543576
Start Date: 2026-01-31
End Date: 2032-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Infinite

Biospecimen Collection

Brachytherapy

Cisplatin

External Beam Radiation Therapy

Paclitaxel

Pembrolizumab

Administration questionnaire

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Study ID: NCT06713473
Start Date: 2026-08
End Date: 2028-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Rehumanized Intervention

Control Intervention

Clinical Interview

Self-Report Measures

Blood Draw

Sponsor

Florida State University

Source: clinicaltrials.gov

Share:
Add to list